US FDA finds procedural issues at Lupin’s plant in Nagpur

US FDA finds procedural issues at Lupin’s plant in Nagpur

Nagpur: The US Federal Drug Administration (US FDA) found several procedural deficiencies at Lupin Limited’s injectables Unit Two in Nagpur following its inspection on October 17-29, according to the form 483 issued by the drug regulator, reported Moneycontrol. Lupin, in an...

by Nagpur Today | Published 2 years ago
US FDA finds procedural issues at Lupin’s plant in Nagpur
By Nagpur Today On Tuesday, November 8th, 2022

US FDA finds procedural issues at Lupin’s plant in Nagpur

Nagpur: The US Federal Drug Administration (US FDA) found several procedural deficiencies at Lupin Limited’s injectables Unit Two in Nagpur following its inspection on October 17-29, according to the form 483 issued by the drug regulator, reported Moneycontrol. Lupin, in an...